Literature DB >> 31825413

Improved RNA modification mapping of cellular non-coding RNAs using C- and U-specific RNases.

Priti Thakur1, Mariana Estevez, Peter A Lobue, Patrick A Limbach, Balasubrahmanyam Addepalli.   

Abstract

Locating ribonucleoside modifications within an RNA sequence requires digestion of the RNA into oligoribonucleotides of amenable size for subsequent analysis by LC-MS (liquid chromatography-mass spectrometry). This approach, widely referred to as RNA modification mapping, is facilitated through ribonucleases (RNases) such as T1 (guanosine-specific), U2 (purine-selective) and A (pyrimidine-specific) among others. Sequence coverage by these enzymes depends on positioning of the recognized nucleobase (such as guanine or purine or pyrimidine) in the sequence and its ribonucleotide composition. Using E. coli transfer RNA (tRNA) and ribosomal RNA (rRNA) as model samples, we demonstrate the ability of complementary nucleobase-specific ribonucleases cusativin (C-specific) and MC1 (U-specific) to generate digestion products that facilitate confident mapping of modifications in regions such as G-rich and pyrimidine-rich segments of RNA, and to distinguish C to U sequence differences. These enzymes also increase the number of oligonucleotide digestion products that are unique to a specific RNA sequence. Further, with these additional RNases, multiple modifications can be localized with high confidence in a single set of experiments with minimal dependence on the individual tRNA abundance in a mixture. The sequence overlaps observed with these complementary digestion products and that of RNase T1 improved sequence coverage to 75% or above. A similar level of sequence coverage was also observed for the 2904 nt long 23S rRNA indicating their utility has no dependence on RNA size. Wide-scale adoption of these additional modification mapping tools could help expedite the characterization of modified RNA sequences to understand their structural and functional role in various living systems.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31825413      PMCID: PMC7002195          DOI: 10.1039/c9an02111f

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  86 in total

Review 1.  Chaplet column chromatography: isolation of a large set of individual RNAs in a single step.

Authors:  Takeo Suzuki; Tsutomu Suzuki
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

2.  Two-dimensional liquid chromatography-mass spectrometry for the characterization of modified oligonucleotide impurities.

Authors:  Stilianos G Roussis; Isaiah Cedillo; Claus Rentel
Journal:  Anal Biochem       Date:  2018-06-22       Impact factor: 3.365

Review 3.  RNA epigenetics and cardiovascular diseases.

Authors:  Lisa E Dorn; Simon Tual-Chalot; Konstantinos Stellos; Federica Accornero
Journal:  J Mol Cell Cardiol       Date:  2019-03-14       Impact factor: 5.000

4.  Global identification of transfer RNAs by liquid chromatography-mass spectrometry (LC-MS).

Authors:  Collin Wetzel; Patrick A Limbach
Journal:  J Proteomics       Date:  2011-09-29       Impact factor: 4.044

5.  Differentiating Positional Isomers of Nucleoside Modifications by Higher-Energy Collisional Dissociation Mass Spectrometry (HCD MS).

Authors:  Manasses Jora; Andrew P Burns; Robert L Ross; Peter A Lobue; Ruoxia Zhao; Cody M Palumbo; Peter A Beal; Balasubrahmanyam Addepalli; Patrick A Limbach
Journal:  J Am Soc Mass Spectrom       Date:  2018-06-12       Impact factor: 3.109

6.  The role of posttranscriptional modification in stabilization of transfer RNA from hyperthermophiles.

Authors:  J A Kowalak; J J Dalluge; J A McCloskey; K O Stetter
Journal:  Biochemistry       Date:  1994-06-28       Impact factor: 3.162

7.  AlkAniline-Seq: Profiling of m7 G and m3 C RNA Modifications at Single Nucleotide Resolution.

Authors:  Virginie Marchand; Lilia Ayadi; Felix G M Ernst; Jasmin Hertler; Valérie Bourguignon-Igel; Adeline Galvanin; Annika Kotter; Mark Helm; Denis L J Lafontaine; Yuri Motorin
Journal:  Angew Chem Int Ed Engl       Date:  2018-11-16       Impact factor: 15.336

Review 8.  Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity.

Authors:  Samantha L Goldman; Ciaran Hassan; Mihir Khunte; Arielle Soldatenko; Yunji Jong; Ebrahim Afshinnekoo; Christopher E Mason
Journal:  Front Genet       Date:  2019-03-01       Impact factor: 4.599

9.  Sensitive and quantitative probing of pseudouridine modification in mRNA and long noncoding RNA.

Authors:  Wen Zhang; Matthew J Eckwahl; Katherine I Zhou; Tao Pan
Journal:  RNA       Date:  2019-06-21       Impact factor: 4.942

10.  Landscape of the complete RNA chemical modifications in the human 80S ribosome.

Authors:  Masato Taoka; Yuko Nobe; Yuka Yamaki; Ko Sato; Hideaki Ishikawa; Keiichi Izumikawa; Yoshio Yamauchi; Kouji Hirota; Hiroshi Nakayama; Nobuhiro Takahashi; Toshiaki Isobe
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

View more
  11 in total

1.  From canonical to modified nucleotides: balancing translation and metabolism.

Authors:  Federica Accornero; Robert L Ross; Juan D Alfonzo
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-16       Impact factor: 8.250

2.  RNA Cleavage Properties of Nucleobase-Specific RNase MC1 and Cusativin Are Determined by the Dinucleotide-Binding Interactions in the Enzyme-Active Site.

Authors:  Priti Thakur; Jowad Atway; Patrick A Limbach; Balasubrahmanyam Addepalli
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

3.  Identification and mapping of post-transcriptional modifications on the HIV-1 antisense transcript Ast in human cells.

Authors:  Mariana Estevez; Rui Li; Biplab Paul; Kaveh Daneshvar; Alan C Mullen; Fabio Romerio; Balasubrahmanyam Addepalli
Journal:  RNA       Date:  2022-02-15       Impact factor: 5.636

4.  Pytheas: a software package for the automated analysis of RNA sequences and modifications via tandem mass spectrometry.

Authors:  Luigi D'Ascenzo; Anna M Popova; Scott Abernathy; Kai Sheng; Patrick A Limbach; James R Williamson
Journal:  Nat Commun       Date:  2022-05-03       Impact factor: 17.694

Review 5.  Role of m6A in osteoporosis, arthritis and osteosarcoma (Review).

Authors:  Yibo Hu; Xiaohui Zhao
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

Review 6.  Naturally occurring modified ribonucleosides.

Authors:  Phillip J McCown; Agnieszka Ruszkowska; Charlotte N Kunkler; Kurtis Breger; Jacob P Hulewicz; Matthew C Wang; Noah A Springer; Jessica A Brown
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-04-16       Impact factor: 9.349

Review 7.  Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers.

Authors:  Dawei Rong; Guangshun Sun; Fan Wu; Ye Cheng; Guoqiang Sun; Wei Jiang; Xiao Li; Yi Zhong; Liangliang Wu; Chuanyong Zhang; Weiwei Tang; Xuehao Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

8.  Oxidative Damage to RNA is Altered by the Presence of Interacting Proteins or Modified Nucleosides.

Authors:  Mariana Estevez; Satenik Valesyan; Manasses Jora; Patrick A Limbach; Balasubrahmanyam Addepalli
Journal:  Front Mol Biosci       Date:  2021-07-01

9.  Characterization of UVA-Induced Alterations to Transfer RNA Sequences.

Authors:  Congliang Sun; Patrick A Limbach; Balasubrahmanyam Addepalli
Journal:  Biomolecules       Date:  2020-11-08

Review 10.  Challenges with Simulating Modified RNA: Insights into Role and Reciprocity of Experimental and Computational Approaches.

Authors:  Rebecca J D'Esposito; Christopher A Myers; Alan A Chen; Sweta Vangaveti
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.